Title : Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.

Pub. Date : 2008 Oct

PMID : 18713253






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 TE risk may be elevated with combination regimens, notably thalidomide/lenalidomide plus high-dose dexamethasone; concomitant erythropoietin appears to further increase the risk with lenalidomide-dexamethasone. Lenalidomide erythropoietin Homo sapiens